Product Information
AB928 is a monoclonal antibody that targets micro-environments in the tumor. It has been shown to be effective in clinical studies for cancer patients, specifically atrial levels and camp levels. AB928 binds to ATP and ADP, which are involved in the regulation of cell metabolism and cell proliferation, respectively. This drug also inhibits tumor growth by targeting response element-binding protein (RBP). RBP is a transcription factor that regulates gene expression and is expressed on the surface of human cells. The binding of AB928 to RBP inhibits the activation of genes that promote tumor growth.
Chemical properties
Technical inquiry about: 3D-PPD27334 AB928
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
